![Yi Larson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yi Larson
Director/Board Member at
OLEMA PHARMACEUTICALS, INC.
Net worth: - $ as of 30/05/2026
Profile
Ms. Yi Larson is an Independent Director at Olema Pharmaceuticals, Inc. She is on the Board of Directors at Olema Pharmaceuticals, Inc. and Rayzebio, Inc. Ms. Larson was previously employed as a Chief Financial Officer & Executive Vice President by Turning Point Therapeutics, Inc. She received her undergraduate degree from The Wharton School of the University of Pennsylvania, a graduate degree from Massachusetts Institute of Technology and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LIANBIO -.--% | 09/04/2023 | 0 ( -.--% ) | - $ | 30/05/2026 |
| 22/04/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Yi Larson active positions
| Companies | Position | Start |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Director/Board Member | 05/04/2021 |
Expedition Therapeutics, Inc.
 Expedition Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel treatments for inflammatory and respiratory diseases | Chief Executive Officer | 31/03/2024 |
Former positions of Yi Larson
| Companies | Position | End |
|---|---|---|
| RAYZEBIO, INC. | Director/Board Member | 25/02/2024 |
| LIANBIO | Director of Finance/CFO | 18/12/2023 |
| TURG POIN | Director of Finance/CFO | 30/03/2021 |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Training of Yi Larson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Expedition Therapeutics, Inc.
Expedition Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel treatments for inflammatory and respiratory diseases | Health Technology |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
LianBio
 LianBio BiotechnologyHealth Technology Operates as a biotechnology company focused on bringing paradigm-shifting medicines to patients | Health Technology |
- Stock Market
- Insiders
- Yi Larson
